{
  "author": {
    "name": "Julie Olson",
    "webUrl": "/author/profile/julie-olson/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 1,
    "social": [],
    "articles": [
      {
        "uri": "/2020/12/24/pharma-benefits-in-2021-4-trends-to-watch/",
        "title": "Pharma benefits in 2021: 4 trends to watch",
        "byline": "Julie Olson",
        "kicker": "Expert Opinion",
        "prettyDate": "December 24, 2020",
        "timeToRead": "5 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2020/03/PharmaReceipt.jpg",
          "width": "0",
          "height": "0"
        },
        "authors": [
          {
            "webUrl": "/author/profile/julie-olson/",
            "name": "Julie Olson"
          }
        ],
        "kickerNode": [
          {
            "uri": "/expert-opinion/",
            "sectionName": "Expert Opinion"
          }
        ],
        "summary": "While organizations will continue to invest in PBM partners to achieve cost savings, a few key areas will drive significant impact in 2021.",
        "body": null
      }
    ]
  }
}